Cargando…
miR-486 suppresses the development of osteosarcoma by regulating PKC-δ pathway
Osteosarcoma is one of the most highly malignant types of cancer in adolescents and young adults with a high mortality rate. Despite advances in surgery, radiation therapy and chemotherapy, the prognosis for patients with osteosarcoma has not significantly improved over the past several decades. It...
Autores principales: | He, Ming, Wang, Guangbin, Jiang, Linlin, Qiu, Chuang, Li, Bin, Wang, Jiashi, Fu, Yonghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403184/ https://www.ncbi.nlm.nih.gov/pubmed/28339053 http://dx.doi.org/10.3892/ijo.2017.3928 |
Ejemplares similares
-
miR-486 suppresses the development of osteosarcoma by regulating PKC-δ pathway
por: He, Ming, et al.
Publicado: (2023) -
miR-141-3p is a key negative regulator of the EGFR pathway in osteosarcoma
por: Wang, Jiashi, et al.
Publicado: (2018) -
Naringin targets Zeb1 to suppress osteosarcoma cell proliferation and metastasis
por: Ming, He, et al.
Publicado: (2018) -
miR-627-3p inhibits osteosarcoma cell proliferation and metastasis by targeting PTN
por: He, Ming, et al.
Publicado: (2019) -
miR-486-5p expression is regulated by DNA methylation in osteosarcoma
por: Namløs, Heidi M., et al.
Publicado: (2022)